SCHEMBL2710058

SCHEMBL2710058

COc1ccc(-c2c3cc(F)c(F)cc3c(-c3c(F)c(F)cc(F)c3F)c3c(F)cccc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.40
MAOB P27338 2/20 0.39
SYK P43405 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
CYP1A2 P05177 3/20 0.36
CYP3A4 P08684 3/20 0.36
CYP2C9 P11712 3/20 0.36
CYP2C19 P33261 3/20 0.36
ALDH1A1 P00352 2/20 0.36
ENPP1 P22413 1/20 0.36
ABL1 P00519 1/20 0.35
ABCB1 P08183 1/20 0.35
BCR P11274 1/20 0.35
CYP2D6 P10635 1/20 0.34
NPC1 O15118 2/20 0.34
TP53 P04637 2/20 0.34
MAPT P10636 2/20 0.34
NFKB1 P19838 2/20 0.34
RAB9A P51151 2/20 0.34
NFKB2 Q00653 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2710211 0.93 ACHE (0.41) ACHEMAOBSYKL3MBTL1CYP1A2
SCHEMBL2710023 0.90 ACHE (0.39) ACHEMAOBSYKL3MBTL1CYP1A2
SCHEMBL2709843 0.90 ACHE (0.40) ACHEMAOBSYKL3MBTL1CYP1A2
SCHEMBL2726756 0.88 ACHE (0.38) ACHEMAOBSYKL3MBTL1CYP1A2
SCHEMBL12086081 0.88 ACHE (0.41) ACHEMAOBSYKL3MBTL1CYP1A2
SCHEMBL2726193 0.88 ACHE (0.41) ACHEMAOBSYKL3MBTL1CYP1A2
SCHEMBL2729138 0.87 ACHE (0.37) ACHEMAOBSYKL3MBTL1CYP1A2
SCHEMBL2733810 0.87 ENPP1 (0.40) ACHEMAOBSYKL3MBTL1CYP1A2
SCHEMBL2712151 0.86 ACHE (0.47) ACHEMAOBSYKL3MBTL1CYP3A4
SCHEMBL2709972 0.85 ALDH1A1 (0.33) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
EP-2445987-B1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECH INC (US) 2018-05-02 EP disclosed
US-8257620-B2 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. (US) 2012-09-04 US disclosed
EP-2445987-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS Cyalume Technologies, Inc (US) 2012-05-02 EP disclosed
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYALUME TECHNOLOGIES, INC. 2010-12-30 US disclosed
WO-2010151654-A1 BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS CYALUME TECHNOLOGIES, INC. (US) 2010-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100327240-A1 Blue/violet diphenylanthracene chemiluminescent fluorescers CYP2F1, FLAD1, AFF1 ACHE 187/4885MAOB 67/4885SYK 2951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.